PACS vs. ENSG, NHC, HOLX, BAX, LH, AVTR, DGX, BMRN, BGNE, and RVTY
Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include The Ensign Group (ENSG), National HealthCare (NHC), Hologic (HOLX), Baxter International (BAX), Laboratory Co. of America (LH), Avantor (AVTR), Quest Diagnostics (DGX), BioMarin Pharmaceutical (BMRN), BeiGene (BGNE), and Revvity (RVTY). These companies are all part of the "medical" sector.
The Ensign Group (NASDAQ:ENSG) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, community ranking, dividends, profitability, valuation, media sentiment and analyst recommendations.
In the previous week, The Ensign Group had 4 more articles in the media than PACS Group. MarketBeat recorded 4 mentions for The Ensign Group and 0 mentions for PACS Group. PACS Group's average media sentiment score of 1.07 beat The Ensign Group's score of 0.00 indicating that The Ensign Group is being referred to more favorably in the media.
96.1% of The Ensign Group shares are owned by institutional investors. 3.9% of The Ensign Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
The Ensign Group has a net margin of 5.67% compared to The Ensign Group's net margin of 0.00%. PACS Group's return on equity of 17.60% beat The Ensign Group's return on equity.
The Ensign Group received 341 more outperform votes than PACS Group when rated by MarketBeat users. However, 100.00% of users gave PACS Group an outperform vote while only 66.10% of users gave The Ensign Group an outperform vote.
The Ensign Group presently has a consensus target price of $124.60, indicating a potential upside of 4.35%. PACS Group has a consensus target price of $31.00, indicating a potential upside of 3.13%. Given PACS Group's higher probable upside, equities research analysts plainly believe The Ensign Group is more favorable than PACS Group.
The Ensign Group has higher revenue and earnings than PACS Group.
Summary
The Ensign Group beats PACS Group on 10 of the 13 factors compared between the two stocks.
Get PACS Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PACS Group Competitors List
Related Companies and Tools
